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During the cruise phase to Mars…
• A crewmember complains of a dull, aching periumbilical pain
• The pain migrates to the RLQ within several hours of onset
• Followed by nausea, anorexia, and general feeling of malaise
• The Crew Medical Officer finds…
• Fever to 38.9°C
• Positive Psoas and Obturator signs on exam
• Ultrasound is inconclusive
• Now what?
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Background
• Even the healthiest persons can develop surgical disease
• Most common operative illnesses in a healthy population
• Acute Appendicitis  7-8% lifetime risk*
• Acute Cholecystitis  20% U.S. adults >40 yo w/ biliary calculi*
• The Fear: Rupture  Peritonitis  Sepsis  Death 
• Extremely limited surgical capacity aboard spacecraft
*Stewart B, et al. Br J Surg 2014.
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Prior Research Did Not Quantify Risk
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Hypothesis
• Are there benefits to prophylactic surgery for exploration missions?
• The incidence of small bowel obstruction (SBO) associated with 
prophylactic surgery will NOT exceed the risk of acute appendicitis 
and/or cholecystitis during an extended-duration space mission
• If true, then prophylactic surgery may be useful
6 of 20
Methods – Integrated Medical Model
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Methods – Integrated Medical Model
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• 6-person crew 
• 2.5-year Mars mission
• Model parameters
• Sex
• Coronary Artery Calcium Score
• Dental Crowns
• Number of Extravehicular Activities
• History of Prior Abdominal Surgery
• 231 EVA excursions
Methods – Design Reference Mission (DRM)
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DRM Description
SBO
(mean events
per person 
year)*
Best Case / 
Worst Case
Control No abdominal surgery 0 n.a.
LA Prophylactic LA, appendicitis = 0 0.0016 75% / 25%
LC Prophylactic LC, cholecystitis = 0 0.0006 67% / 33%
LA + LC Prophylactic LA & LC, both = 0 0.0022 67% / 33%
Methods – Design Reference Missions (DRMs)
*Angenete E, et al. JAMA 2012.
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Model Limitations
• Baselined to the ISS medical capabilities and environment
• Medical conditions are all correctly diagnosed
• All treatments are 100% effective
• No timeline
• Medical conditions are independent of each other
• Same crewmember can EVAC/LOCL more than once
Uncertainty ranges not represented in the modified input data
Model limitations generally result in conservative estimates
when compared to the real world
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Model Outcomes of Interest
• Evacuation (EVAC): 
• Consideration of evacuation when treatment capability exceeded
• EVAC from Mars is not an option, still useful to assess risk
• Loss of Crew Life (LOCL):
• Death due to severity of illness or exceeding treatment capacity
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Results – EVAC Probability
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Results – LOCL Probability
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Results
Benefits of prophylactic surgery do NOT 
outweigh the risks of small bowel obstruction
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Discussion
• Surgical advances may alter true risk
• Single-incision laparoscopy
• Natural Orifice Transluminal Endoscopic Surgery (NOTES)
• Robotic surgery
• Other risks that are not in the model:
• Risk of abdominal wall hernias
• Physiologic changes with spaceflight 
• Effectiveness of conservative treatment
16 of 20
Additional Considerations
• Ethics
• Prophylactic surgery itself is not without risks
• Surgery could lead to disqualifying complication
• Crewmember autonomy vs. pressure to comply
• NASA is obligated to minimize as many risks as possible
• Changes to policy?
• Agreement/participation of partner countries?
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Summary
• Acute Appendicitis and Cholecystitis may threaten crew health
• Prophylactic surgery does not justify risks at this time
• Future surgical techniques may negate risks of SBO
• Addressing uncertainty range in input data, and applying 
newest version of IMM may addresses model limitations
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Thank you!
Questions?
• Carroll, D., et al., A Risk-Benefit Analysis of Prophylactic 
Surgery before Extended-Duration Spaceflight, In-Preparation, 
to be submitted to AMHP, May 2017
Questions?
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Results - EVAC and LOCL Probabilities 
DRM EVAC* EVAC 95% CI LOCL* LOCL 95% CI
Control 0.1768 0.1745 - 0.1792 0.0241 0.0232 - 0.0251
LA 0.1839 0.1814 - 0.1862 0.0233 0.0223 - 0.0242
LC 0.1804 0.1780 - 0.1828 0.0247 0.0238 - 0.0257
LA + LC 0.1878 0.1854 - 0.1902 0.0239 0.0230 - 0.0249
S-20160407-351* Probability of one or more events
